Scoring of hepatocyte steatosis, ballooning, lobular inflammation, and liver fibrosis was then performed to reveal the role of lipidomics-affecting APOC3 SNPs in NAFLD-specific pathological alterations. The gene discussed is APOC3; the disease is metabolic dysfunction-associated steatotic liver disease.